Antibody Drug Conjugates: What’s New and What to Know
Antibody-drug conjugates (ADCs) are a type of targeted therapy used to treat metastatic breast cancer (MBC). ADCs are sometimes called “smart drugs”...
Read More PAST ARTICLES
2025
- The Importance of Diversity in MBC Clinical Trials
- Research for Metastatic Inflammatory Breast Cancer
- What Should I do if I Decide to Leave a Clinical Trial?
- What Happens Before Starting Treatment in a Clinical Trial?
- What is Immunotherapy?
- How to Talk to Family Members About Clinical Trials
- Overcoming Resistance to Hormone Therapy
- Understanding Liquid Biopsies for MBC
- What Should I Do if My Clinical Trial Ends Early?
2024
- Combining Radiation and Immunotherapy Treatment for MBC
- Can I Know if My MBC Treatment is Likely to Work?
- Newly Diagnosed with MBC: Advice from People with MBC
- The Latest in Treatments for MBC With Brain Metastases
- Update: New Biomarkers Can Now be Used to Select Treatment for MBC
- What is “Drug Sequencing”?
- Discovering New Ways to Overcome Treatment Resistance in Triple-Negative MBC
2022
- Which Foods, Supplements, and Drugs Should I Avoid During MBC Treatment?
- Why You Should Consider Repeat Biopsies
- Oncolytic Viruses: Using Viruses to Kill Cancer Cells
- What is it Like to Participate in a Clinical Trial?
- Why Knowing Your HER2 Status is Important
- How To Choose a Cancer Center
- Breast Cancer Brain Metastasis: Highlighting the Experts
- Why Do Some People Have an Exceptional Response When Being Treated for MBC?
2020
SEARCH OUR SITE
for past articles or specific information.